Vaxcyte Cash from 2010 to 2024

PCVX Stock  USD 89.40  1.01  1.14%   
Vaxcyte Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 290.5 M in 2024. Cash is the total amount of money in the form of currency that Vaxcyte has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2019-12-31
Previous Quarter
518.7 M
Current Value
1.1 B
Quarterly Volatility
285.4 M
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 66.1 M, Interest Expense of 0.0 or Selling General Administrative of 63.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.16. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Cash Growth Pattern

Below is the plot of the Cash of Vaxcyte over the last few years. Cash refers to the most liquid asset of Vaxcyte, which is listed under current asset account on Vaxcyte balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Vaxcyte customers. The amounts must be unrestricted with restricted cash listed in a different Vaxcyte account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Vaxcyte's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Vaxcyte Cash Regression Statistics

Arithmetic Mean159,463,284
Geometric Mean78,996,192
Coefficient Of Variation143.18
Mean Deviation169,457,750
Median36,139,000
Standard Deviation228,312,565
Sample Variance52126.6T
Range798.5M
R-Value0.64
Mean Square Error32893.6T
R-Squared0.41
Significance0.01
Slope32,850,103
Total Sum of Squares729772.8T

Vaxcyte Cash History

2024290.5 M
2023397.5 M
2022834.7 M
202169 M
2020386.2 M
201959 M
201866.1 M

Other Fundumenentals of Vaxcyte

Vaxcyte Cash component correlations

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.